IRTC vs JCI · rev $423.6M vs P/E 44, rev $23.60B
iRhythm Technologies Inc (IRTC) versus Johnson Controls International PLC (JCI) — a side-by-side from cached financials, not a winner call.
iRhythm Technologies Inc (IRTC) is a medical devices company listed on US.
Johnson Controls International PLC (JCI) is a building products & equipment company listed on NYSE.
Latest reported IRTC revenue for 2026-06-30 was $423.6M. Net income was -$14.3M. IRTC currently screens at market cap $4.55B.
Latest reported JCI revenue for 2025-09-30 was $23.60B. Net income was $3.51B. JCI currently screens at market cap $87.62B and trailing P/E 43.9.
IRTC currently screens at market cap $4.55B. JCI currently screens at market cap $87.62B and trailing P/E 43.9.
Not investment advice. Open the IRTC and JCI stock pages for the full models.
Not investment advice.